高渗盐水治疗低钠血症:达标与避害
高渗盐水用于低钠血症近一个世纪,共识认为伴中重度症状者应使用以预防神经并发症,但给药方式、剂量、静脉通路、是否联用去氨加压素等存在争议。本文回顾历史与近期证据,就适应证、剂量、给药途径、联用去氨加压素及液体限制等提出实用建议。
要点
- 伴中重度症状的低钠血症应使用高渗盐水预防神经并发症。
- 给药方式、剂量、静脉通路及联用去氨加压素等细节专家意见不一。
- 本文基于近期证据提出高渗盐水使用的实用建议。
核心结论
- 高渗盐水应于伴中重度症状的低钠血症以预防神经并发症,但给药方式、剂量、通路及联用去氨加压素等细节尚存争议。
研究设计与样本
- 本文为综述,回顾高渗盐水治疗低钠血症的历史起源与近期证据,并给出实用建议。
主要发现
- 专家对高渗盐水应弹丸注射还是持续输注、合适剂量、是否需中心静脉通路、是否联用去氨加压素及其时长等问题意见不一。
临床怎么用
- 对伴中重度症状的低钠血症使用高渗盐水,并关注给药方式、剂量、通路、联用去氨加压素及液体限制等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hypertonic saline has been used for the treatment of hyponatremia for nearly a century. There is now general consensus that hypertonic saline should be used in patients with hyponatremia associated with moderate or severe symptoms to prevent neurological complications. However, much less agreement exists among experts regarding other aspects of its use. Should hypertonic saline be administered as a bolus injection or continuous infusion? What is the appropriate dose? Is a central venous line necessary? Should desmopressin be used concomitantly and for how long? This article considers these important questions, briefly explores the historical origins of hypertonic saline use for hyponatremia, and reviews recent evidence behind its indications, dosing, administration modality and route, combined use with desmopressin to prevent rapid correction of serum sodium, and other considerations such as the need and degree for fluid restriction. The authors conclude by offering some practical recommendations for the use of hypertonic saline.
引用
- Rondon-Berrios H, Sterns RH. Hypertonic Saline for Hyponatremia: Meeting Goals and Avoiding Harm. Am J Kidney Dis. 2021. PMID: 34508830. doi:10.1053/j.ajkd.2021.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。